Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma

Bradley A. McGregor, Michael S. Gordon, Ronan Flippot, Neeraj Agarwal, Saby George, David I. Quinn, Mark Rogalski, Thomas Hawthorne, Tibor Keler, Toni K. Choueiri